/en/lp/blog/industries/africa-pharma-overview
Africa Pharma: Powering Reliable Pharmaceutical Supply Chains Across the Continent
12/11/2026
Key Takeaways:
- Africa’s pharma industry keeps showing potential for major growth, with some forecasts even putting the sector at $56 billion to $70 billion by 2030. Through expanding their manufacturing, rising investment, and a growing focus on medical security, Africa is preparing to emerge as a dominant force in the pharmaceutical sector.
- Local production is being built on stronger supply foundations. Growth in active pharmaceutical ingredients (APIs), chemical inputs, and botanicals, alongside the progress of industrial hubs such as South Africa, Egypt, Morocco, Kenya, Nigeria, and Rwanda, aims to reduce import dependence and strengthen regional pharmaceutical manufacturing.
- Logistics and cold chain capability are key to future growth. Reliable transport, temperature control, and stronger infrastructure help move medicines safely, support regional distribution, and enable Africa’s pharma industry to scale.
This progress is attracting international investors looking to expand into new markets, while also supporting Africa’s economic growth and strengthening its global trading position. By expanding local production, reducing reliance on imports, and creating new export opportunities, the pharma sector is playing a growing role in the continent’s wider development.
This progress is attracting international investors looking to expand into new markets, while also supporting Africa’s economic growth and strengthening its global trading position. By expanding local production, reducing reliance on imports, and creating new export opportunities, the pharma sector is playing a growing role in the continent’s wider development.
Did you know?
Building Africa’s API Supply Base
Africa is beginning to play a larger role in pharmaceutical raw material supply, with ongoing efforts to strengthen local API (Active Pharmaceutical Ingredient) production and reduce dependence on imports.
As the continent works towards producing 60% of its health products like vaccines by 2040, this shift stands on three key foundations: natural resources, chemical inputs, and botanicals.
Natural Resources
Chemical Inputs
Botanicals and Medicinal Plants
However, developing this into a reliable supply base depends on continued investment in research, cultivation, quality control, processing, and regulation to ensure consistent and safe use at scale.
The African Hubs Shaping Pharmaceutical Manufacturing
Several countries are playing an important role in strengthening Africa’s pharmaceutical sector, each contributing in different ways:
South Africa
South Africa has a well-established pharmaceutical base, supported by both multinational and local manufacturers. It produces a range of generics, biologics, vaccines, and higher-value formulations, supported by relatively advanced logistics and distribution networks.
Egypt
Egypt remains one of Africa’s largest pharmaceutical producers, with a mature generics industry and strong formulation capabilities. Ongoing regulatory improvements and industrial investment are helping the country gradually expand into more advanced manufacturing segments.Morocco
Morocco has made steady progress by aligning with international GMP standards and improving its logistics infrastructure. This has supported growth in higher-value formulations and enabled expansion into regional export markets.
Egypt
Egypt remains one of Africa’s largest pharmaceutical producers, with a mature generics industry and strong formulation capabilities. Ongoing regulatory improvements and industrial investment are helping the country gradually expand into more advanced manufacturing segments.Morocco
Morocco has made steady progress by aligning with international GMP standards and improving its logistics infrastructure. This has supported growth in higher-value formulations and enabled expansion into regional export markets.Kenya
As a key trade and transport hub, Kenya plays a central role in pharmaceutical distribution across East and Central Africa. While still mid-sized (~$750M–$1B (2024–2025 range)), fast-growing pharmaceutical market, increasing healthcare demand, population growth, and expanding access to healthcare are driving steady growth. Although the country remains reliant on imported medicines and active pharmaceutical ingredients (APIs), continued investment in local manufacturing, warehousing, and regulation is strengthening its position as a regional supplier of generic, over-the-counter (OTC), and essential medicines. With most pharmaceutical manufacturing, headquarters, and distribution centres concentrated in Nairobi, Kenya also serves as an important gateway for supplying neighbouring East African markets.
Nigeria
Nigeria’s pharmaceutical sector is gaining momentum through regulatory improvements, investment in quality standards, and efforts to expand local production. Growing distribution networks are also supporting regional integration across West Africa.
Rwanda
Rwanda is investing in building a future pharmaceutical hub, supported by initiatives such as the Rwanda FDA and the African Pharmaceutical Technology Foundation (APTF). These developments are aimed at strengthening local capabilities in production and regulation over time.
The Need for Reliable Pharmaceutical logistics in Africa
Logistics continues to play a critical role in supporting Africa’s pharmaceutical sector. As demand grows, supply chains must evolve to ensure medicines are transported safely and efficiently.
Because many pharmaceutical products, including vaccines, require strict temperature control, cold chain solutions are becoming increasingly important. Expanding cold chain infrastructure across logistics hubs will be key to maintaining product quality and reducing the risk of spoilage.
At the same time, reliable transport, visibility, and tracking systems are essential to ensure medicines reach their destination on time, supporting both patient needs and wider supply chain performance.
What’s Next for Africa Pharma?
Africa’s pharmaceutical sector has made meaningful progress, but there is still significant potential to be realised. Continued investment, stronger partnerships, and supportive policies will all play an important role in shaping the next phase of growth.
As manufacturing capabilities develop and supply chains become more integrated, Africa is well positioned to strengthen its role in global pharmaceutical production. While challenges remain, the direction of travel is clear, and the long-term outlook for the sector remains positive.
Ask MSC
Reliable pharmaceutical supply chains depend on more than cargo movement alone. They rely on strong cold chain performance, dependable inland logistics, and the visibility needed to keep sensitive shipments moving safely across Africa. At MSC, we support Africa pharma with shipping solutions designed to help protect product integrity, improve coordination, and strengthen supply chain confidence across the continent.
Contact us today to find out more.
Our Solutions
Shipping Solutions
Learn More
Inland Transportation & Logistics Solutions
Learn More
Digital Business Solutions
Learn More
Warehousing & Storage Solutions
Learn MoreRelated Articles
Freight Shipping to Africa: Trends, Challenges, and Opportunities for 2026
With over 30 coastal nations and a network of major container ports, Africa is one of the world’s most strategic destinations for international cargo transportation. Through the handling of containerized consumer goods, industrial machinery, agricultural, automotive commodities, energy and mining equipment, as a continent, Africa plays a critical role in the supply chains for businesses across many industries.
Shipping Dangerous Goods
The UN Model Regulations separate dangerous or hazardous substances into nine classes all of which can pose a threat to human and animal life, material property, or the environment if they leak or are mishandled in any way. These classes are not ordered in terms of severity but by substance type. Each class of hazardous goods determines how the cargo can be shipped and what measures need to be in place throughout transportation.
Expert Advice: Utilizing Cold Chain Solutions to Serve Your Customers
Helping to protect goods from exposure to temperature variants during transportation, temperature-controlled shipping forms a vital part of numerous industries’ approach to cold chain solutions. By ensuring that temperatures remain regulated throughout transportation, this type of cold chain solution helps preserve the quality, safety, and effectiveness of your cargo while it reaches its final destination.
Chilled to Perfection: The Benefits of Using Refrigerated Shipping Containers
As the types of food consumed worldwide become ever more varied, there has been an increasing pressure on businesses to consistently deliver top quality, fresh produce year-round. To meet this consumer demand, the transportation of perishable goods has had to become increasingly efficient and reliable, necessitating the use of refrigerated shipping containers worldwide.